Fingerprint
Dive into the research topics of 'Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas
Shivaani Kummar, Alice Chen, Jiuping Ji, Yiping Zhang, Joel M. Reid, Matthew Ames, Lee Jia, Marcie Weil, Giovanna Speranza, Anthony J. Murgo, Robert Kinders, Lihua Wang, Ralph E. Parchment, John Carter, Howard Stotler, Larry Rubinstein, Melinda Hollingshead, Giovanni Melillo, Yves Pommier, William Bonner
Research output: Contribution to journal › Article › peer-review
222
Scopus
citations